THE SITUATION
- The public is concerned about drug abuse/misuse and environmental contamination from improper disposal.
- Legislation mandating drug take-back programs targets manufacturers, who’ll bear the cost of these programs.
- As more states conform, the cost to manufacturers will rise.
- Disjointed, jurisdiction-specific laws present a major compliance challenge.